Skip to content
Log in
Sponsored Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt
Review

Recent strategies and approaches for the development of molecularly targeted nanomedicine.

Aman Kumar Md Hidul Islam Pranav Dhingra Abhishek Sharma Sneha Kumari Komal Chaudhary Preeti Patel Balak Das Kurmi
2026 · Advances in Protein Chemistry and Structural Biology · Vol 153, pp. 1-57 · 0 citations
Medicine

TL;DR

This chapter highlights the role of targeting ligands, stimuli-responsive systems, and tumor microenvironment-specific strategies in enhancing therapeutic efficacy while minimizing adverse effects, emphasizing the potential of molecularly targeted nanomedicine to advance precision therapy and improve clinical outcomes.

DOI PubMed Semantic Scholar
View source

Similar papers

Review Open access Aug 2026

Cancer Nanomedicine: Advanced Nanocarrier Systems, Targeted Drug Delivery, Theranostics, and Emerging Strategies for Precision Oncology

Overall, cancer nanomedicine has evolved from a simple drug-delivery concept into a multifunctional therapeutic platform integrating targeted therapy, molecular imaging, immunomodulation, gene therapy, and personalized medicine.

Fouzan Arif Mulla Mulla, M. Khan, Irfan Nizamuddin Mansuri Mansuri et al. · 0 citations
Open access Sep 2026

Innovative nanomedicine strategies for precision-controlled targeted drug delivery: recent preclinical progress

Nanomedicine has emerged as a transformative strategy for precision-controlled drug delivery. It addresses key limitations of conventional therapeutics such as poor tissue selectivity, rapid degradation, and systemic toxicity. By employing nanoscale carriers (including lipid-based systems, polymeric nanoparticles, in...

Ashna Sureshkumar, Prakash Balu · 0 citations
Review Open access 2026

The evolution of active targeting in cancer therapy: bridging molecular biomarkers and intelligent nanomedicine

Despite the success of present-day chemotherapy, the shortcomings in this treatment, such as the lack of tumor selectivity, systemic toxicity, multidrug resistances, and insufficient therapeutic effects, still pose a challenge for successful clinical management of cancer. Active targeting to address these challenges ha...

M. Karthick, Rajesh Akkena, K. Loganathan · 0 citations
Review Open access Sep 2026

Next-generation nanomedicine for cancer therapy: advances, challenges, and future perspectives

In recent times, permeation of nanotechnology to modern medicine has revolutionized transformation, especially in the case of cancer diagnosis and therapy, positioning nanomedicine as a key pillar of next-generation healthcare. Tuning the physicochemical properties of nanoparticles such as size, morphology, and surface...

Biswajit Mohanty, P. Saikia, Piyush Pandey et al. · 0 citations
Review Open access Aug 2026

Engineering strategies and translational progress in targeted nanoparticle drug delivery.

This review comprehensively examines major nanocarrier platforms, including lipid-based, polymeric, inorganic, and hybrid systems, with emphasis on their structural design and functional properties.

Nithya Ajay, Anu Shibi Anilkumar, R. Veerabathiran · 0 citations
Open access Sep 2026

Nanocarrier Platforms in Cancer Therapeutics: Design, Advances and Clinical Translation Challenges

Nanotechnology has emerged as a transformative frontier for detecting and treating various types of tumours more accurately. As a leading technology, nanotechnology assists in overcoming the issues linked with traditional antitumor drug systems. Nanocarriers (NCs) are colloidal systems developed for precise drug delive...

Shalu Tiwari, Abhijeet Ojha, A. Singh et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.